A Double-Blind, Placebo-Controlled, Parallel-Group, 12-Week Trial to Assess the Efficacy and Safety of MK0663 in Patients With Chronic Low Back Pain.
Phase of Trial: Phase III
Latest Information Update: 12 May 2009
At a glance
- Drugs Etoricoxib (Primary)
- Indications Back pain
- Focus Therapeutic Use
- Sponsors Merck & Co
- 11 Nov 2006 New trial record.